PortfoliosLab logo
CLOV vs. LUMN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CLOV and LUMN is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

CLOV vs. LUMN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and Lumen Technologies, Inc. (LUMN). The values are adjusted to include any dividend payments, if applicable.

-80.00%-60.00%-40.00%-20.00%0.00%20.00%December2025FebruaryMarchAprilMay
-62.75%
-50.13%
CLOV
LUMN

Key characteristics

Sharpe Ratio

CLOV:

4.08

LUMN:

1.71

Sortino Ratio

CLOV:

4.64

LUMN:

3.33

Omega Ratio

CLOV:

1.57

LUMN:

1.41

Calmar Ratio

CLOV:

4.36

LUMN:

2.26

Martin Ratio

CLOV:

24.60

LUMN:

5.97

Ulcer Index

CLOV:

17.10%

LUMN:

36.05%

Daily Std Dev

CLOV:

83.78%

LUMN:

133.45%

Max Drawdown

CLOV:

-97.16%

LUMN:

-95.26%

Current Drawdown

CLOV:

-82.85%

LUMN:

-79.87%

Fundamentals

Market Cap

CLOV:

$1.69B

LUMN:

$4.34B

EPS

CLOV:

-$0.09

LUMN:

-$0.32

PS Ratio

CLOV:

1.23

LUMN:

0.33

PB Ratio

CLOV:

4.95

LUMN:

13.42

Total Revenue (TTM)

CLOV:

$1.02B

LUMN:

$13.00B

Gross Profit (TTM)

CLOV:

$283.04M

LUMN:

$5.52B

EBITDA (TTM)

CLOV:

-$22.08M

LUMN:

$3.77B

Returns By Period

In the year-to-date period, CLOV achieves a 19.05% return, which is significantly higher than LUMN's -21.66% return.


CLOV

YTD

19.05%

1M

8.07%

6M

2.18%

1Y

330.74%

5Y*

N/A

10Y*

N/A

LUMN

YTD

-21.66%

1M

28.40%

6M

-54.73%

1Y

225.00%

5Y*

-12.35%

10Y*

-13.40%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CLOV vs. LUMN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV
The Risk-Adjusted Performance Rank of CLOV is 9999
Overall Rank
The Sharpe Ratio Rank of CLOV is 100100
Sharpe Ratio Rank
The Sortino Ratio Rank of CLOV is 9999
Sortino Ratio Rank
The Omega Ratio Rank of CLOV is 9797
Omega Ratio Rank
The Calmar Ratio Rank of CLOV is 9898
Calmar Ratio Rank
The Martin Ratio Rank of CLOV is 9999
Martin Ratio Rank

LUMN
The Risk-Adjusted Performance Rank of LUMN is 9393
Overall Rank
The Sharpe Ratio Rank of LUMN is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of LUMN is 9696
Sortino Ratio Rank
The Omega Ratio Rank of LUMN is 9494
Omega Ratio Rank
The Calmar Ratio Rank of LUMN is 9494
Calmar Ratio Rank
The Martin Ratio Rank of LUMN is 8989
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CLOV vs. LUMN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Lumen Technologies, Inc. (LUMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current CLOV Sharpe Ratio is 4.08, which is higher than the LUMN Sharpe Ratio of 1.71. The chart below compares the historical Sharpe Ratios of CLOV and LUMN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.006.00December2025FebruaryMarchAprilMay
4.08
1.71
CLOV
LUMN

Dividends

CLOV vs. LUMN - Dividend Comparison

Neither CLOV nor LUMN has paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
CLOV
Clover Health Investments, Corp.
0.00%0.00%0.00%0.00%2.69%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LUMN
Lumen Technologies, Inc.
0.00%0.00%0.00%14.37%7.97%10.26%7.57%14.26%12.95%9.08%8.59%5.46%

Drawdowns

CLOV vs. LUMN - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.16%, roughly equal to the maximum LUMN drawdown of -95.26%. Use the drawdown chart below to compare losses from any high point for CLOV and LUMN. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%December2025FebruaryMarchAprilMay
-82.85%
-69.70%
CLOV
LUMN

Volatility

CLOV vs. LUMN - Volatility Comparison

The current volatility for Clover Health Investments, Corp. (CLOV) is 16.32%, while Lumen Technologies, Inc. (LUMN) has a volatility of 24.06%. This indicates that CLOV experiences smaller price fluctuations and is considered to be less risky than LUMN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%December2025FebruaryMarchAprilMay
16.32%
24.06%
CLOV
LUMN

Financials

CLOV vs. LUMN - Financials Comparison

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Lumen Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-1.00B0.001.00B2.00B3.00B4.00B5.00B20212022202320242025
336.96M
3.18B
(CLOV) Total Revenue
(LUMN) Total Revenue
Values in USD except per share items

CLOV vs. LUMN - Profitability Comparison

The chart below illustrates the profitability comparison between Clover Health Investments, Corp. and Lumen Technologies, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%20212022202320242025
27.9%
47.0%
(CLOV) Gross Margin
(LUMN) Gross Margin
CLOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a gross profit of 93.92M and revenue of 336.96M. Therefore, the gross margin over that period was 27.9%.

LUMN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Lumen Technologies, Inc. reported a gross profit of 1.50B and revenue of 3.18B. Therefore, the gross margin over that period was 47.0%.

CLOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported an operating income of -21.45M and revenue of 336.96M, resulting in an operating margin of -6.4%.

LUMN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Lumen Technologies, Inc. reported an operating income of 107.00M and revenue of 3.18B, resulting in an operating margin of 3.4%.

CLOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a net income of -22.09M and revenue of 336.96M, resulting in a net margin of -6.6%.

LUMN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Lumen Technologies, Inc. reported a net income of -201.00M and revenue of 3.18B, resulting in a net margin of -6.3%.